07/12/12Amarin shares plunge on decision to hire own sales force for Vascepa launch
14/11/11Amarin to present positive results from two phase 3 studies of anti-triglyceride drug
26/09/11Amarin submits NDA for triglyceride-lowering AMR101 drug
18/04/11Amarin shares surge on phase III results of triglyceride-lowering drug
Recent Sector News
Bedrocan is an experienced producer of pharmaceutical grade medical marijuana, according to Dundee, with over 13 years of growing expertise through Dutch partner and shareholder Bedrocan BV.
Shares of Agenus (NASDAQ:AGEN) rocketed more than 30 percent today after the company announced a co-development collaboration with Incyte (NASDAQ:INCY) to develop immuno-oncology antibodies.
Alliqua's (NASDAQ:ALQA) shares are currently undervalued as it expands its wound care capabilities through acquisitions and partnerships, according to analysts at H.C. Wainwright, which has initiated coverage on the company with a buy rating and 12-month target of $10.00 per share.
Pressure BioSciences (OTCQB:PBIO) has shipped its third new Barozyme high throughput HT48 system to the Funk Laboratory of the Feinberg School of Medicine at Northwestern, the company said Wednesday.
Pressure BioSciences installs first 2 Barozyme high throughput systems, expects to ship next 3 in the coming weeks
Pressure BioSciences (OTCQB:PBIO) says it has installed its first two Barozyme HT-48 high throughput systems for independent evaluation and potential sale.
Pressure BioSciences posts 14% rise in Q3 products and services revenue, growth expected to continue
Pressure BioSciences (OTCQB:PBIO) said it continued to trim its operating loss as products and services revenue climbed 14 percent in the third quarter.
Investors interested in Amarin recently viewed
- Deltex Medical Group plc (AIM: DEMG) ....Save lives....Save bed days....Save money....
- Proteomics International Laboratories (ASX: PIQ) .
- ValiRx (AIM: VAL) Developing technologies & products in oncology therapeutics & diagnostics
- African Medical Investments (AIM: AMEI) Capital Appreciation through Private Healthcare in Africa
- Regeneus Limited (ASX: RGS) .